84
Views
4
CrossRef citations to date
0
Altmetric
Original Paper

Synthesis, crystal structure and antimicrobial activity of a novel oxidovanadium(V) complex with tridentate Schiff base ligand

, &
Pages 286-290 | Received 09 Feb 2018, Accepted 16 Jul 2018, Published online: 31 Dec 2018
 

Abstract

A novel oxidovanadium complex, [VOLL’]·CH3OH, where L is the dianionic form of 3-((3-bromo-2-hydroxyphenyl)-{[1-(3-bromo-2-hydroxyphenyl)methylidene]amino}methyl)pentane-2,4-dione (H2L), L’ is 1,10-phenanthroline, was prepared and characterized by spectroscopic and single crystal X-ray diffraction. The complex crystallizes as the monoclinic space group Cc, with unit cell dimensions a = 18.806(2) Å, b = 14.960(2) Å, c = 12.954(2) Å, β = 123.719(2)°, V = 3031.5(6) Å3, Z = 4, R1 = 0.0638, wR2 = 0.0825, Goof =1.069. X-ray analysis indicates that the complex is a mononuclear oxidovanadiumm(V) species, with the V atom in octahedral coordination. The complex was evaluated for their antibacterial (Bacillus subtilis, Staphylococcus aureus, Escherichia coli, and Pseudomonas fluorescence) and antifungal (Candida albicans and Aspergillus niger) activities by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) method. Interestingly, the complex has strong activity against S. aureus.

Acknowledgment

This work was financially supported by K.C. Wong Magna Fund in Ningbo University, Ningbo natural science fund (project no. 201701HJ-B01019) and College students of science and technology innovation projects in Zhejiang province and Ningbo city (project no. 2017R405008 and 2017YZD001).

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.